Horizontal eye movements and neuronal activity in the vestibular nuclei and pretectum were recorded in albino and pigmented rats in response to optokinetic, vestibular (VS), combined visual-vestibular (VVS) sinusoidal stimulations. 1. VOR slow phase velocity in VS condition leads head velocity. This phase lead is smaller in albino than in pigmented rats. 2. Presence of vision (VVS) improves the phase angle of the VOR in both strains, especially at low frequencies. In pigmented rats the VOR is perfectly compensatory with respect to phase at all frequencies whereas in albinos the eye velocity still leads the head velocity. 3. There is no difference in the response characteristics of vestibular nuclear neurons (VN) to VS between albino and pigmented rats which could explain the difference in their VORs. 4. In the pigmented rat, there is a strong optokinetic input to VN which provokes a shift of the response peak towards peak head velocity. These visual-vestibular interactions at VN level are in agreement with the changes in the phase angle of the VOR. 5. In albino rat, there are no differences in the response characteristics of VN between VS and VVS, thus the decrease of the VOR phase lead observed in VVS compared to VS is due either to visual-vestibular interactions outside of the vestibular nuclei or to some general arousing effect of light. 6. Recording of responses of pretectal neurons to visual stimulation in albino rats has shown that they are activated in a phasic or tonic way by light on ("On cells") or off ("Off cells"). Contrary to the pigmented rat, pretreated neurons in albino exhibited no detectable direction specific optokinetic responses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF00582389 | DOI Listing |
Nutrients
January 2025
Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Yanpu Township 90741, Taiwan.
: This study investigated the wound-healing potential of hispolon, a polyphenolic pigment derived from medicinal mushrooms, under diabetic conditions using both in vitro and in vivo models. : In the in vitro assays, L929 fibroblast cells exposed to high glucose (33 mmol/L) were treated with hispolon at concentrations of 2.5, 5, 7.
View Article and Find Full Text PDFFront Plant Sci
January 2025
Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.
Introduction: is a medicinal plant that produces silymarin, which has been demonstrated to possess antiviral, anti-neurodegenerative, and anticancer activities. Silybin (A+B) are two major hepatoprotective flavonolignans produced predominantly in fruits. Several attempts have been made to increase the synthesis of silymarin, or its primary components, silybin (A+B).
View Article and Find Full Text PDFSci Rep
January 2025
Department of Biological and Geological Sciences, Faculty of Education, Alexandria University, Alexandria, 21526, Egypt.
Hydroxyapatite nanoparticles (HANPs) have been applied in several biomedical fields. However, its interaction with biological systems is less exploited. This study aimed to characterize HANPs, examine their influence on kidneys, and explore the potential protective effects of naturally extracted red pigment (RP) from Monascus purpureus against HANPs-induced renal toxicity.
View Article and Find Full Text PDFJ Appl Toxicol
January 2025
School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
Sulcardine sulfate (Sul) is a novel antiarrhythmic agent blocking multiple channels and exhibits unique pharmacological properties such as lower APD-dependent prolongation and reduced arrhythmia risk. Sul is currently in Phase III clinical trials, yet studies on its long-term toxicological profile and potential target organs remain unexplored. This study investigated the related toxicity of Sul in Sprague Dawley (SD) rats through repeated oral administration for 26 weeks, followed by a 4-week recovery period.
View Article and Find Full Text PDFArch Toxicol
February 2025
Oregon State University, Corvallis, OR, USA.
The kinetically-derived maximal dose (KMD) is defined as the maximum external dose at which kinetics are unchanged relative to lower doses, e.g., doses at which kinetic processes are not saturated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!